Sam Chun Dang Pharm. Co. Ltd
Buy, Hold or Sell?
Let's analyze Sam Chun Dang Pharm. Co. Ltd together
I guess you are interested in Sam Chun Dang Pharm. Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.
I'm going to help you getting a better view of Sam Chun Dang Pharm. Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.
Get notifications about Sam Chun Dang Pharm. Co. Ltd
I send you an email if I find something interesting about Sam Chun Dang Pharm. Co. Ltd.
1. Quick Overview
1.1. Quick analysis of Sam Chun Dang Pharm. Co. Ltd (30 sec.)
1.2. What can you expect buying and holding a share of Sam Chun Dang Pharm. Co. Ltd? (30 sec.)
How much money do you get?
What is your share worth?
+ What do you gain per year?
2. Detailed Analysis
2.1. Valuation of Sam Chun Dang Pharm. Co. Ltd (5 min.)
2.2. Growth of Sam Chun Dang Pharm. Co. Ltd (5 min.)
Is Sam Chun Dang Pharm. Co. Ltd growing?
Current year | Previous year | Grow | Grow % | |
---|---|---|---|---|
How rich? | $210.1m | $125.9m | $62.9m | 33.3% |
How much money is Sam Chun Dang Pharm. Co. Ltd making?
Current year | Previous year | Grow | Grow % | |
---|---|---|---|---|
Making money | -$1.6m | $764.4k | -$2.4m | -145.5% |
Net Profit Margin | -5.2% | 2.4% | - | - |
How much money comes from the company's main activities?
2.3. Financial Health of Sam Chun Dang Pharm. Co. Ltd (5 min.)
2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)
Industry Rankings (Pharmaceuticals)
3. Summary and Key Metrics
3.1. What can you expect buying and holding a share of Sam Chun Dang Pharm. Co. Ltd?
Welcome investor! Sam Chun Dang Pharm. Co. Ltd's management wants to use your money to grow the business. In return you get a share of Sam Chun Dang Pharm. Co. Ltd.
First you should know what it really means to hold a share of Sam Chun Dang Pharm. Co. Ltd. And how you can make/lose money.
Speculation
The Price per Share of Sam Chun Dang Pharm. Co. Ltd is ₩131,800. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.
If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:
- The fundamentals: the financial health trends of Sam Chun Dang Pharm. Co. Ltd.
- The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
- The book value: what is the market price compared to it's book value.
Investing
If you really want to invest in Sam Chun Dang Pharm. Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:
- You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩13,189.38. Based on the TTM, the Book Value Change Per Share is ₩1,177.32 per quarter. Based on the YOY, the Book Value Change Per Share is ₩127.62 per quarter.
- You may receive quarterly/yearly dividend in the form of additional shares.
- You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩9.85 per quarter.
How much money are you going to get?
MRQ | TTM | YOY | 5Y | 10Y | ||||||
---|---|---|---|---|---|---|---|---|---|---|
₩ | % of Price per Share | ₩ | % of Price per Share | ₩ | % of Price per Share | ₩ | % of Price per Share | ₩ | % of Price per Share | |
Usd Eps | 0.04 | 0.0% | -0.07 | 0.0% | 0.03 | 0.0% | -0.02 | 0.0% | 0.04 | 0.0% |
Usd Book Value Change Per Share | 0.05 | 0.0% | 0.82 | 0.0% | 0.09 | 0.0% | 0.12 | 0.0% | 0.13 | 0.0% |
Usd Dividend Per Share | 0.00 | 0.0% | 0.01 | 0.0% | 0.02 | 0.0% | 0.03 | 0.0% | 0.04 | 0.0% |
Usd Total Gains Per Share | 0.05 | 0.0% | 0.83 | 0.0% | 0.10 | 0.0% | 0.15 | 0.0% | 0.17 | 0.0% |
Usd Price Per Share | 98.42 | - | 61.18 | - | 33.22 | - | 38.06 | - | 25.56 | - |
Price to Earnings Ratio | 701.82 | - | 168.62 | - | 614.87 | - | 163.54 | - | 91.88 | - |
Price-to-Total Gains Ratio | 1,885.74 | - | 572.59 | - | 297.47 | - | 50.75 | - | 87.07 | - |
Price to Book Ratio | 10.66 | - | 7.24 | - | 5.79 | - | 5.97 | - | 4.07 | - |
Price-to-Total Gains Ratio | 1,885.74 | - | 572.59 | - | 297.47 | - | 50.75 | - | 87.07 | - |
When do you get the money?
Usd Investment | |
---|---|
Usd Price Per Share | 92.26 |
Number of shares | 10 |
Gains per Quarter | Trailing 12 Months | 5 Year |
---|---|---|
Usd Dividend Per Share | 0.01 | 0.03 |
Usd Book Value Change Per Share | 0.82 | 0.12 |
Usd Total Gains Per Share | 0.83 | 0.15 |
Gains per Quarter (10 shares) | 8.31 | 1.54 |
Gains per Year (10 shares) | 33.24 | 6.16 |
Years | Return on Investment (TTM) | Return on Investment (5Y) | ||||
---|---|---|---|---|---|---|
Dividend | Book Value gain | Total gains | Dividend | Book Value gain | Total gains | |
Broker costs | - | - | -10 | - | - | -10 |
1 | 0 | 33 | 23 | 1 | 5 | -4 |
2 | 1 | 66 | 56 | 3 | 10 | 2 |
3 | 1 | 99 | 89 | 4 | 15 | 8 |
4 | 1 | 132 | 122 | 5 | 20 | 14 |
5 | 1 | 165 | 155 | 6 | 24 | 20 |
6 | 2 | 198 | 188 | 8 | 29 | 26 |
7 | 2 | 231 | 221 | 9 | 34 | 32 |
8 | 2 | 264 | 254 | 10 | 39 | 38 |
9 | 2 | 297 | 287 | 12 | 44 | 44 |
10 | 3 | 330 | 320 | 13 | 49 | 50 |
How sure are you?
Based on the past periods, how sure are you to get value out of your investment.
Linear %
Trailing 12 Months | 3Y | 5 Year | 10 Year | ALLTIME | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% | % | % | % | % | ||||||||||||||||
Earnings Per Share | 2.0 | 2.0 | 0.0 | 50.0% | 7.0 | 5.0 | 0.0 | 58.3% | 12.0 | 8.0 | 0.0 | 60.0% | 30.0 | 9.0 | 1.0 | 75.0% | 35.0 | 9.0 | 1.0 | 77.8% |
Book Value Change Per Share | 4.0 | 0.0 | 0.0 | 100.0% | 8.0 | 4.0 | 0.0 | 66.7% | 12.0 | 8.0 | 0.0 | 60.0% | 30.0 | 10.0 | 0.0 | 75.0% | 34.0 | 11.0 | 0.0 | 75.6% |
Dividend per Share | 1.0 | 0.0 | 3.0 | 25.0% | 7.0 | 0.0 | 5.0 | 58.3% | 14.0 | 0.0 | 6.0 | 70.0% | 30.0 | 0.0 | 10.0 | 75.0% | 34.0 | 0.0 | 11.0 | 75.6% |
Total Gains per Share | 4.0 | 0.0 | 0.0 | 100.0% | 8.0 | 4.0 | 0.0 | 66.7% | 13.0 | 7.0 | 0.0 | 65.0% | 32.0 | 8.0 | 0.0 | 80.0% | 37.0 | 8.0 | 0.0 | 82.2% |
3.2. Key Performance Indicators
The key performance indicators of Sam Chun Dang Pharm. Co. Ltd compared to the Most Recent Quarter (MRQ).
End of day | +/- | Most Recent Quarter | Trailing 12 Months | +/- | Year-Over-Year | +/- | 5 Year | +/- | 10 Year | +/- | |
---|---|---|---|---|---|---|---|---|---|---|---|
Book Value Change Per Share | - | - | 74.560 | 1177.319 | -94% | 127.623 | -42% | 174.112 | -57% | 186.562 | -60% |
Book Value Per Share | - | - | 13189.376 | 11901.859 | +11% | 8123.020 | +62% | 8879.010 | +49% | 8444.562 | +56% |
Current Ratio | - | - | 2.690 | 2.290 | +17% | 3.798 | -29% | 3.714 | -28% | 2.810 | -4% |
Debt To Asset Ratio | - | - | 0.274 | 0.340 | -19% | 0.523 | -48% | 0.436 | -37% | 0.303 | -10% |
Debt To Equity Ratio | - | - | 0.511 | 0.666 | -23% | 1.096 | -53% | 0.843 | -39% | 0.561 | -9% |
Dividend Per Share | - | - | - | 9.845 | -100% | 21.940 | -100% | 46.050 | -100% | 56.143 | -100% |
Eps | - | - | 50.084 | -106.582 | +313% | 49.435 | +1% | -30.218 | +160% | 51.518 | -3% |
Gross Profit Margin | - | - | 1.000 | 1.000 | 0% | 1.000 | 0% | 1.000 | 0% | 0.975 | +3% |
Market Cap | 2821284440000.000 | -13% | 3199700563200.000 | 1982317236750.000 | +61% | 1053446567250.000 | +204% | 1199917114700.000 | +167% | 799725380900.000 | +300% |
Net Profit Margin | - | - | 0.024 | -0.052 | +320% | 0.024 | -4% | -0.017 | +173% | 0.031 | -23% |
Operating Margin | - | - | - | - | 0% | 0.039 | -100% | 0.012 | -100% | 0.031 | -100% |
Operating Ratio | - | - | 1.009 | 1.226 | -18% | 0.853 | +18% | 0.820 | +23% | 0.804 | +25% |
Pb Ratio | 9.993 | -7% | 10.660 | 7.241 | +47% | 5.795 | +84% | 5.966 | +79% | 4.075 | +162% |
Pe Ratio | 657.893 | -7% | 701.819 | 168.620 | +316% | 614.871 | +14% | 163.540 | +329% | 91.881 | +664% |
Price Per Share | 131800.000 | -7% | 140600.000 | 87400.000 | +61% | 47462.500 | +196% | 54375.000 | +159% | 36512.250 | +285% |
Price To Free Cash Flow Ratio | - | - | - | -38.005 | 0% | -49.171 | 0% | -28.451 | 0% | -12.541 | 0% |
Price To Total Gains Ratio | 1767.711 | -7% | 1885.737 | 572.588 | +229% | 297.466 | +534% | 50.749 | +3616% | 87.066 | +2066% |
Quick Ratio | - | - | - | 1.168 | -100% | 4.459 | -100% | 3.535 | -100% | 2.555 | -100% |
Return On Assets | - | - | 0.003 | -0.006 | +315% | 0.003 | -6% | -0.002 | +157% | 0.006 | -56% |
Return On Equity | - | - | 0.005 | -0.012 | +336% | 0.006 | -16% | -0.003 | +162% | 0.010 | -48% |
Total Gains Per Share | - | - | 74.560 | 1187.165 | -94% | 149.563 | -50% | 220.162 | -66% | 242.705 | -69% |
Usd Book Value | - | - | 210109803.400 | 188853545.675 | +11% | 125924735.647 | +67% | 136753345.294 | +54% | 128412265.713 | +64% |
Usd Book Value Change Per Share | - | - | 0.052 | 0.824 | -94% | 0.089 | -42% | 0.122 | -57% | 0.131 | -60% |
Usd Book Value Per Share | - | - | 9.233 | 8.331 | +11% | 5.686 | +62% | 6.215 | +49% | 5.911 | +56% |
Usd Dividend Per Share | - | - | - | 0.007 | -100% | 0.015 | -100% | 0.032 | -100% | 0.039 | -100% |
Usd Eps | - | - | 0.035 | -0.075 | +313% | 0.035 | +1% | -0.021 | +160% | 0.036 | -3% |
Usd Free Cash Flow | - | - | - | 1452329.702 | -100% | -2961371.277 | 0% | -793023.551 | 0% | 2209384.616 | -100% |
Usd Market Cap | 1974899108.000 | -13% | 2239790394.240 | 1387622065.725 | +61% | 737412597.075 | +204% | 839941980.290 | +167% | 559807766.630 | +300% |
Usd Price Per Share | 92.260 | -7% | 98.420 | 61.180 | +61% | 33.224 | +196% | 38.063 | +159% | 25.559 | +285% |
Usd Profit | - | - | 797851.600 | -1679875.559 | +311% | 764478.157 | +4% | -475118.347 | +160% | 761130.754 | +5% |
Usd Revenue | - | - | 33920103.700 | 34469878.994 | -2% | 31442704.836 | +8% | 31349310.813 | +8% | 28539604.713 | +19% |
Usd Total Gains Per Share | - | - | 0.052 | 0.831 | -94% | 0.105 | -50% | 0.154 | -66% | 0.170 | -69% |
EOD | +3 -4 | MRQ | TTM | +17 -12 | YOY | +13 -16 | 5Y | +16 -13 | 10Y | +12 -19 |
3.3 Fundamental Score
Penke's Stock Scanner
Indicator | Condition | Value | ||
---|---|---|---|---|
Price to Earnings Ratio (EOD) | Between | 0-15 | 657.893 | |
Price to Book Ratio (EOD) | Between | 0-1 | 9.993 | |
Net Profit Margin (MRQ) | Greater than | 0 | 0.024 | |
Operating Margin (MRQ) | Greater than | 0 | 0.000 | |
Quick Ratio (MRQ) | Greater than | 1 | 0.000 | |
Current Ratio (MRQ) | Greater than | 1 | 2.690 | |
Debt to Asset Ratio (MRQ) | Less than | 1 | 0.274 | |
Debt to Equity Ratio (MRQ) | Less than | 1 | 0.511 | |
Return on Equity (MRQ) | Greater than | 0.15 | 0.005 | |
Return on Assets (MRQ) | Greater than | 0.05 | 0.003 | |
Total | 4/10 (40.0%) |
3.4 Technical Score
Penke's Symbol Scanner
Indicator | Condition | Value | ||
---|---|---|---|---|
Rsi | Greater than | 50 | 36.359 | |
Ma 20 | Greater than | Ma 50 | 144,540.000 | |
Ma 50 | Greater than | Ma 100 | 166,464.000 | |
Ma 100 | Greater than | Ma 200 | 145,800.000 | |
Open | Greater than | Close | 134,400.000 | |
Total | 3/5 (60.0%) |
4. In-depth Analysis
4.1 About Sam Chun Dang Pharm. Co. Ltd
- https://www.scd.co.kr
- Pharmaceuticals
- 375
- 351 Hyoryeong-ro, Seoul, South Korea, 06643
Google Maps Bing Maps
Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea.
Fundamental data was last updated by Penke on 2024-08-23 17:48:07.
4.2 In-depth Summary
4.2.1. Financial Health Summary
Compared to previous year | Compared to industry | |
---|---|---|
The company is making a loss. | ||
Using its assets, the company is very inefficient in making profit. | ||
Using its investors money, the company is very inefficient in making profit. |
Compared to previous year | Compared to industry | |
---|---|---|
The company is inefficient in keeping operating costs low. |
Compared to previous year | Compared to industry | |
---|---|---|
The company is able to pay all its short-term debts. | ||
The company is just able to pay all its short-term debts with the most liquid assets. |
Compared to previous year | Compared to industry | |
---|---|---|
The company is very able to pay all its debts by selling its assets. | ||
The company is very able to pay all its debts with equity. |
4.2.2. Valuation Summary
Compared to previous year | Compared to industry | |
---|---|---|
Based on the equity, the company is overpriced. | ||
Based on the earnings, the company is expensive. | ||
Based on how much money comes from the company's main activities, the company is expensive. |
4.3 Financial Health
4.3.1. Profitability
4.3.1 Profitability
4.3.1.1. Net Profit Margin
- Above 10% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
- A Net Profit Margin of 2.4% means that ₩0.02 for each ₩1 in revenue is generated as profit.
Let's take a look of the Net Profit Margin trends of Sam Chun Dang Pharm. Co. Ltd:
Trends
- The YOY is 2.4%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -1.7%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 3.1%. Compared to the 5Y term, the 10Y term is trending down. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 2.4% | TTM | -5.2% | +7.5% | |
TTM | -5.2% | YOY | 2.4% | -7.6% | |
TTM | -5.2% | 5Y | -1.7% | -3.5% | |
5Y | -1.7% | 10Y | 3.1% | -4.8% |
Compared to industry (Pharmaceuticals)
Let compare the company's Net Profit Margin with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 9.6%. trending down. -2
- The TTM average (mean) in the Pharmaceuticals industry is 8.8%. trending down. -2
4.3.1.2. Return on Assets
- Above 5% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
- 0.3% Return on Assets means that Sam Chun Dang Pharm. Co. Ltd generated ₩0.00 profit for each $1 in assets.
Let's take a look of the Return on Assets trends of Sam Chun Dang Pharm. Co. Ltd:
Trends
- The YOY is 0.3%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -0.2%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 0.6%. Compared to the 5Y term, the 10Y term is trending down. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.3% | TTM | -0.6% | +0.9% | |
TTM | -0.6% | YOY | 0.3% | -0.9% | |
TTM | -0.6% | 5Y | -0.2% | -0.4% | |
5Y | -0.2% | 10Y | 0.6% | -0.8% |
Compared to industry (Pharmaceuticals)
Let compare the company's Return on Assets with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 2.9%. trending down. -2
- The TTM average (mean) in the Pharmaceuticals industry is 2.8%. trending down. -2
4.3.1.3. Return on Equity
- Above 15%-20% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
- 0.5% Return on Equity means Sam Chun Dang Pharm. Co. Ltd generated ₩0.01 for each ₩1 the owners (shareholders) invested.
Let's take a look of the Return on Equity trends of Sam Chun Dang Pharm. Co. Ltd:
Trends
- The YOY is 0.6%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -0.3%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 1.0%. Compared to the 5Y term, the 10Y term is trending down. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.5% | TTM | -1.2% | +1.7% | |
TTM | -1.2% | YOY | 0.6% | -1.8% | |
TTM | -1.2% | 5Y | -0.3% | -0.9% | |
5Y | -0.3% | 10Y | 1.0% | -1.3% |
Compared to industry (Pharmaceuticals)
Let compare the company's Return on Equity with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 4.3%. trending down. -2
- The TTM average (mean) in the Pharmaceuticals industry is 4.0%. trending down. -2
4.3.2. Operating Efficiency of Sam Chun Dang Pharm. Co. Ltd.
4.3.2. Operating Efficiency
4.3.2.1. Operating Margin
- Measures how much profit Sam Chun Dang Pharm. Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
- Above 15% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
- An Operating Margin of 0.0% means the company generated ₩0.00 for each ₩1 in revenue (before taxes).
Let's take a look of the Operating Margin trends of Sam Chun Dang Pharm. Co. Ltd:
- The MRQ is 0.0%. The data is not here.
Trends
- The 10Y is 3.1%. Compared to the 5Y term, the 10Y term is trending down. -2
Compared to industry (Pharmaceuticals)
Let compare the company's Operating Margin with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 21.8%. trending down. -2
- The TTM average (mean) in the Pharmaceuticals industry is 8.3%. trending down. -2
4.3.2.2. Operating Ratio
- Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
- An Operation Ratio of 1.01 means that the operating costs are ₩1.01 for each ₩1 in net sales.
Let's take a look of the Operating Ratio trends of Sam Chun Dang Pharm. Co. Ltd:
Trends
- The YOY is 0.853. Compared to the TTM, the mid term is trending up. -2
- The 5Y is 0.820. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is 0.804. Compared to the 5Y term, the 10Y term is trending up. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 1.009 | TTM | 1.226 | -0.217 | |
TTM | 1.226 | YOY | 0.853 | +0.372 | |
TTM | 1.226 | 5Y | 0.820 | +0.406 | |
5Y | 0.820 | 10Y | 0.804 | +0.016 |
Compared to industry (Pharmaceuticals)
Let compare the company's Operating Ratio with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 1.286. trending down. +2
- The TTM average (mean) in the Pharmaceuticals industry is 1.231. trending down. +2
4.4.3. Liquidity of Sam Chun Dang Pharm. Co. Ltd.
4.4.3. Liquidity
4.4.3.1. Current Ratio
- Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
- A Current Ratio of 2.69 means the company has ₩2.69 in assets for each ₩1 in short-term debts.
Let's take a look of the Current Ratio trends of Sam Chun Dang Pharm. Co. Ltd:
Trends
- The YOY is 3.798. Compared to the TTM, the mid term is trending down. -2
- The 5Y is 3.714. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 2.810. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 2.690 | TTM | 2.290 | +0.401 | |
TTM | 2.290 | YOY | 3.798 | -1.508 | |
TTM | 2.290 | 5Y | 3.714 | -1.425 | |
5Y | 3.714 | 10Y | 2.810 | +0.905 |
Compared to industry (Pharmaceuticals)
Let compare the company's Current Ratio with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 2.385. trending up. +2
- The TTM average (mean) in the Pharmaceuticals industry is 2.456. trending down. -2
4.4.3.2. Quick Ratio
- Above 1 is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
- A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).
Let's take a look of the Quick Ratio trends of Sam Chun Dang Pharm. Co. Ltd:
- The MRQ is 0.000. The data is not here.
Trends
- The YOY is 4.459. Compared to the TTM, the mid term is trending down. -2
- The 5Y is 3.535. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 2.555. Compared to the 5Y term, the 10Y term is trending up. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | - | TTM | 1.168 | -1.168 | |
TTM | 1.168 | YOY | 4.459 | -3.291 | |
TTM | 1.168 | 5Y | 3.535 | -2.367 | |
5Y | 3.535 | 10Y | 2.555 | +0.980 |
Compared to industry (Pharmaceuticals)
Let compare the company's Quick Ratio with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 0.973. trending down. -2
- The TTM average (mean) in the Pharmaceuticals industry is 1.111. trending up. +2
4.5.4. Solvency of Sam Chun Dang Pharm. Co. Ltd.
4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio
- Below 1 (100%) is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to Pharmaceuticals industry mean.
- A Debt to Asset Ratio of 0.27 means that Sam Chun Dang Pharm. Co. Ltd assets are financed with 27.4% credit (debt) and the remaining percentage (100% - 27.4%) is financed by its owners/shareholders.
Let's take a look of the Debt to Asset Ratio trends of Sam Chun Dang Pharm. Co. Ltd:
Trends
- The YOY is 0.523. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 0.436. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 0.303. Compared to the 5Y term, the 10Y term is trending up. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.274 | TTM | 0.340 | -0.066 | |
TTM | 0.340 | YOY | 0.523 | -0.183 | |
TTM | 0.340 | 5Y | 0.436 | -0.096 | |
5Y | 0.436 | 10Y | 0.303 | +0.133 |
Compared to industry (Pharmaceuticals)
Let compare the company's Debt to Asset Ratio with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 0.316. trending down. +2
- The TTM average (mean) in the Pharmaceuticals industry is 0.313. trending up. -2
4.5.4.2. Debt to Equity Ratio
- Below 2 is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
- A Debt to Equity ratio of 51.1% means that company has ₩0.51 debt for each ₩1 in shareholders equity.
Let's take a look of the Debt to Equity Ratio trends of Sam Chun Dang Pharm. Co. Ltd:
Trends
- The YOY is 1.096. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 0.843. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 0.561. Compared to the 5Y term, the 10Y term is trending up. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | 0.511 | TTM | 0.666 | -0.155 | |
TTM | 0.666 | YOY | 1.096 | -0.430 | |
TTM | 0.666 | 5Y | 0.843 | -0.178 | |
5Y | 0.843 | 10Y | 0.561 | +0.282 |
Compared to industry (Pharmaceuticals)
Let compare the company's Debt to Equity Ratio with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 0.510. trending up. -2
- The TTM average (mean) in the Pharmaceuticals industry is 0.502. trending up. -2
4.6. Market Valuation
4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio
- Above 15 is considered overpriced but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
- A PE ratio of 701.82 means the investor is paying ₩701.82 for every ₩1 in earnings.
Let's take a look of the Price to Earnings Ratio trends of Sam Chun Dang Pharm. Co. Ltd:
Trends
- The YOY is 614.871. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 163.540. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is 91.881. Compared to the 5Y term, the 10Y term is trending up. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
EOD | 657.893 | MRQ | 701.819 | -43.926 | |
MRQ | 701.819 | TTM | 168.620 | +533.200 | |
TTM | 168.620 | YOY | 614.871 | -446.252 | |
TTM | 168.620 | 5Y | 163.540 | +5.079 | |
5Y | 163.540 | 10Y | 91.881 | +71.659 |
Compared to industry (Pharmaceuticals)
Let compare the company's Price to Earnings Ratio with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 21.409. trending up. -2
- The TTM average (mean) in the Pharmaceuticals industry is 21.522. trending up. -2
4.6.2.2. Price To Free Cash Flow Ratio
Let's take a look of the Price To Free Cash Flow Ratio trends of Sam Chun Dang Pharm. Co. Ltd:
- The MRQ is 0.000. The data is not here.
Trends
- The YOY is -49.171. Compared to the TTM, the mid term is trending up. -2
- The 5Y is -28.451. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is -12.541. Compared to the 5Y term, the 10Y term is trending down. +2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
MRQ | - | TTM | -38.005 | +38.005 | |
TTM | -38.005 | YOY | -49.171 | +11.166 | |
TTM | -38.005 | 5Y | -28.451 | -9.554 | |
5Y | -28.451 | 10Y | -12.541 | -15.910 |
Compared to industry (Pharmaceuticals)
Let compare the company's priceToFreeCashFlowRatio with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 25.798. trending down. +2
- The TTM average (mean) in the Pharmaceuticals industry is 25.978. trending down. -2
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio
- At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
- A PB ratio of 10.66 means the investor is paying ₩10.66 for each ₩1 in book value.
Let's take a look of the Price to Book Ratio trends of Sam Chun Dang Pharm. Co. Ltd:
Trends
- The YOY is 5.795. Compared to the TTM, the mid term is trending up. -2
- The 5Y is 5.966. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is 4.075. Compared to the 5Y term, the 10Y term is trending up. -2
Current period | Compared to | +/- | |||
---|---|---|---|---|---|
EOD | 9.993 | MRQ | 10.660 | -0.667 | |
MRQ | 10.660 | TTM | 7.241 | +3.419 | |
TTM | 7.241 | YOY | 5.795 | +1.446 | |
TTM | 7.241 | 5Y | 5.966 | +1.274 | |
5Y | 5.966 | 10Y | 4.075 | +1.892 |
Compared to industry (Pharmaceuticals)
Let compare the company's Price to Book Ratio with the average (mean) in the Pharmaceuticals industry:
- The MRQ average (mean) in the Pharmaceuticals industry is 2.988. trending up. -2
- The TTM average (mean) in the Pharmaceuticals industry is 2.988. trending up. -2
4.6.2. Total Gains per Share
6. Financial Statements
6.1. Latest Balance Sheet
Balance Sheet of 2024-03-31. Currency in KRW. All numbers in thousands.
Summary
As reported | |
---|---|
Total Liabilities | 113,361,462 |
Total Stockholder Equity | + 221,805,311 |
Total Assets | = 413,518,324 |
Assets
Total Current Assets
Total Current Assets (as reported) | 164,493,199 |
---|---|
Total Current Assets (calculated) | 0 |
+/- | 164,493,199 |
Long-term Assets
Long-term Assets (as reported) | 249,025,126 |
---|---|
Long-term Assets (calculated) | 0 |
+/- | 249,025,126 |
Liabilities & Shareholders' Equity
Total Current Liabilities
Total Current Liabilities (as reported) | 61,139,686 |
---|---|
Total Current Liabilities (calculated) | 0 |
+/- | 61,139,686 |
Long-term Liabilities
Long-term Liabilities (as reported) | 52,221,775 |
---|---|
Long-term Liabilities (calculated) | 0 |
+/- | 52,221,775 |
Total Stockholder Equity
Total Stockholder Equity (as reported) | 221,805,311 |
---|---|
Total Stockholder Equity (calculated) | 0 |
+/- | 221,805,311 |
Other
Common Stock Shares Outstanding | 22,757 |
Net Invested Capital | 221,805,311 |
Net Working Capital | 103,353,513 |
6.2. Balance Sheets Structured
Currency in KRW. All numbers in thousands.
Trend | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
> Total Assets |
| 413,518,324 | 408,021,822 | 407,822,828 | 403,547,425 | 393,813,672 | 372,793,050 | 375,762,736 | 365,302,011 | 361,470,284 | 345,996,602 | 343,639,552 | 345,546,175 | 345,331,804 | 317,078,866 | 308,298,061 | 290,127,871 | 291,086,043 | 290,150,966 | 283,175,879 | 271,276,486 | 265,390,933 | 261,158,440 | 242,169,841 | 244,596,118 | 241,361,802 | 235,143,417 | 222,891,131 | 215,540,228 | 210,940,399 | 205,113,463 | 199,295,326 | 193,611,970 | 187,802,246 | 184,260,203 | 180,350,978 | 173,017,326 | 171,174,146 | 172,490,847 | 168,442,151 | 162,511,808 | 159,831,378 | 155,378,650 | 127,827,531 | 123,443,031 | 118,204,920 | |||||||||||||||||||||||||||||||||||||||||||||
> Total Current Assets |
| 164,493,199 | 163,905,938 | 172,244,411 | 171,516,196 | 173,557,812 | 157,749,140 | 178,153,354 | 175,258,759 | 173,982,849 | 168,919,766 | 172,247,307 | 186,685,799 | 173,235,567 | 166,527,651 | 176,227,738 | 159,756,047 | 163,085,830 | 162,492,554 | 162,119,366 | 151,409,701 | 146,058,904 | 142,271,889 | 128,207,154 | 131,979,749 | 137,417,373 | 131,206,711 | 128,516,381 | 121,953,841 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Cash And Cash Equivalents |
| 0 | 40,427,236 | 23,423,716 | 37,141 | 38,350 | 13,953 | 34,903 | 52,467 | 32,317 | 28,117 | 63,350,269 | 77,660,259 | 60,186,193 | 58,882,279 | 51,781,148 | 46,917,144 | 54,780,694 | 60,191,032 | 59,698,170 | 45,933,148 | 46,687,623 | 51,471,447 | 41,847,555 | 55,290,147 | 56,567,833 | 61,906,493 | 57,372,191 | 56,131,091 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Short-term Investments |
| 0 | 52,316,741 | 68,261,920 | 67,163,970 | 72,189,768 | 64,147,606 | 63,587,975 | 59,604,497 | 64,881,830 | 47,911,629 | 36,914,100 | 36,928,640 | 47,060,497 | 38,030,725 | 0 | 0 | 0 | 39,084,293 | 38,300,000 | 38,300,000 | 31,300,000 | 29,292,930 | 19,000,000 | 7,947,335 | 7,947,335 | 1,177,095 | 1,206,227 | 1,206,227 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Net Receivables |
| 0 | 30,426,120 | 36,801,268 | 36,574,365 | 35,617,338 | 35,460,946 | 46,339,632 | 40,406,893 | 40,711,007 | 38,589,321 | 37,113,232 | 39,318,984 | 39,506,239 | 36,540,037 | 45,174,495 | 45,764,936 | 43,321,474 | 38,900,372 | 31,698,686 | 41,778,619 | 43,711,552 | 37,082,484 | 41,560,672 | 39,752,457 | 39,682,429 | 38,863,500 | 41,570,351 | 36,535,734 | 37,182,281 | 38,218,555 | 35,381,930 | 33,931,473 | 32,867,183 | 32,352,192 | 31,633,826 | 30,426,673 | 31,085,768 | 33,406,655 | 31,134,079 | 31,950,528 | 31,235,757 | 30,720,418 | 29,988,525 | 29,754,763 | 29,571,415 | |||||||||||||||||||||||||||||||||||||||||||||
Other Current Assets |
| 0 | 60,842 | 59,181 | 56,379 | 56,636 | 56,188 | 2,273,506 | 253,510 | 160,790 | 260,253 | 4,539,926 | 4,846,374 | 2,482,349 | 2,589,036 | 2,982,583 | 3,626,192 | 783,694 | 798,708 | 521,058 | 1,032,678 | 831,041 | 661,267 | 1,057,721 | 1,038,495 | 3,922,945 | 1,183,845 | 687,070 | 310,039 | 629,299 | 970,883 | 991,024 | 1,325,637 | 1,296,236 | 738,745 | 756,160 | 833,240 | 736,646 | 903,469 | 889,898 | 760,273 | 1,900,354 | 584,510 | 1,160,000 | 726,293 | 579,930 | |||||||||||||||||||||||||||||||||||||||||||||
> Long-term Assets |
| 249,025,126 | 244,115,884 | 235,578,417 | 232,031,229 | 220,255,860 | 215,526,786 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Property Plant Equipment |
| 0 | 90,008,846 | 89,685,922 | 88,166,625 | 86,893,871 | 87,212,078 | 84,772,771 | 83,638,506 | 79,092,197 | 74,112,174 | 66,243,486 | 64,990,130 | 65,078,192 | 63,275,508 | 57,848,540 | 58,486,365 | 57,740,019 | 57,334,229 | 61,547,524 | 60,747,469 | 60,751,939 | 60,726,674 | 60,671,574 | 58,685,308 | 54,355,876 | 55,174,955 | 55,675,840 | 56,450,452 | 56,939,551 | 57,927,531 | 59,070,887 | 58,971,772 | 59,076,891 | 59,307,475 | 59,319,199 | 59,658,904 | 58,046,632 | 54,588,734 | 52,278,480 | 50,674,688 | 49,792,242 | 49,639,229 | 47,645,017 | 48,090,087 | 49,265,949 | |||||||||||||||||||||||||||||||||||||||||||||
Goodwill |
| 0 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | 3,745,081 | |||||||||||||||||||||||||||||||||||||||||||||
Long Term Investments |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32,494,925 | 29,942,948 | 31,409,787 | 31,883,290 | 31,695,971 | 29,221,510 | 29,310,282 | 25,275,648 | 24,842,910 | 16,496,232 | 16,871,437 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Intangible Assets |
| 0 | 92,555,523 | 89,987,702 | 86,284,141 | 82,312,653 | 77,094,982 | 60,089,881 | 53,753,034 | 48,199,640 | 44,685,163 | 33,079,234 | 30,632,294 | 29,818,312 | 29,124,260 | 28,538,608 | 27,939,401 | 27,256,670 | 26,480,199 | 19,458,089 | 9,183,144 | 9,186,537 | 9,190,543 | 9,194,206 | 2,925,153 | 6,672,035 | 6,676,448 | 6,667,069 | 6,661,568 | 6,662,588 | 6,720,181 | 6,723,072 | 6,694,484 | 5,259,930 | 5,197,370 | 5,199,157 | 5,202,578 | 5,205,054 | 5,218,987 | 5,232,252 | 5,243,602 | 3,998,878 | 4,012,089 | 4,070,742 | 4,128,251 | 4,175,717 | |||||||||||||||||||||||||||||||||||||||||||||
Long-term Assets Other |
| 0 | 0 | -1 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
> Total Liabilities |
| 113,361,462 | 109,561,750 | 121,447,838 | 209,376,231 | 204,141,082 | 199,052,091 | 196,167,904 | 188,740,475 | 185,596,700 | 171,901,898 | 166,044,473 | 164,044,288 | 162,979,663 | 130,453,074 | 126,953,237 | 130,205,730 | 133,605,254 | 132,278,810 | 123,083,286 | 57,526,774 | 56,254,529 | 55,394,974 | 34,470,130 | 36,848,887 | 40,015,435 | 36,386,893 | 35,393,950 | 35,273,500 | 36,219,811 | 34,110,755 | 31,421,265 | 30,022,717 | 31,044,075 | 29,945,295 | 30,627,466 | 28,529,251 | 29,626,342 | 32,814,496 | 31,932,870 | 30,324,814 | 37,242,899 | 36,147,194 | 39,533,122 | 38,935,341 | 33,297,381 | |||||||||||||||||||||||||||||||||||||||||||||
> Total Current Liabilities |
| 61,139,686 | 57,957,199 | 96,978,778 | 91,994,977 | 90,259,702 | 38,159,521 | 31,656,376 | 49,962,302 | 52,621,432 | 54,019,011 | 51,589,443 | 32,570,765 | 56,518,434 | 23,658,314 | 34,539,595 | 39,581,659 | 44,181,731 | 45,205,983 | 40,509,142 | 38,788,437 | 37,809,987 | 38,419,138 | 24,895,175 | 26,804,339 | 26,131,194 | 23,699,293 | 25,477,002 | 26,369,253 | 27,694,330 | 26,146,746 | 22,157,547 | 22,076,685 | 22,323,590 | 21,713,551 | 21,629,741 | 20,535,512 | 22,765,178 | 26,547,663 | 25,787,529 | 24,781,644 | 30,766,701 | 29,786,312 | 20,265,217 | 19,977,188 | 21,841,006 | |||||||||||||||||||||||||||||||||||||||||||||
Short-term Debt |
| 0 | 0 | 0 | 22,932,345 | 22,814,876 | 2,755,729 | 2,928,845 | 3,051,205 | 1,980,246 | 1,579,730 | 2,273,210 | 1,989,944 | 1,820,327 | 2,011,004 | 12,622,162 | 2,818,187 | 2,591,934 | 2,439,279 | 2,877,077 | 0 | 10,867,279 | 0 | 3,000,000 | 3,000,000 | 5,244,812 | 5,336,425 | 7,365,073 | 8,195,635 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Short Long Term Debt |
| 0 | 32,225,990 | 65,730,975 | 59,221,506 | 58,835,629 | 2,755,729 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,867,279 | 0 | 3,000,000 | 3,000,000 | 5,244,812 | 5,336,425 | 7,365,073 | 8,195,635 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Accounts payable |
| 0 | 3,861,657 | 4,886,308 | 5,045,564 | 4,817,150 | 4,943,427 | 4,871,316 | 4,678,656 | 4,439,680 | 4,758,228 | 4,494,732 | 3,852,685 | 3,532,885 | 3,177,946 | 3,864,011 | 3,509,146 | 4,929,200 | 3,617,239 | 3,978,706 | 5,030,833 | 4,281,192 | 3,393,207 | 3,786,135 | 4,603,094 | 4,025,662 | 4,434,709 | 4,249,271 | 4,130,483 | 3,797,092 | 3,827,532 | 4,113,351 | 3,665,736 | 3,648,096 | 4,770,235 | 4,813,667 | 4,526,829 | 3,550,892 | 7,320,192 | 5,904,268 | 4,239,215 | 4,810,030 | 3,302,230 | 4,672,470 | 3,214,162 | 3,755,712 | |||||||||||||||||||||||||||||||||||||||||||||
Other Current Liabilities |
| 0 | 1,911,487 | 0 | 1,795,947 | 1,773,488 | 1,771,229 | 13,334,972 | 12,718,929 | 17,697,693 | 18,638,986 | 15,708,780 | 16,595,140 | 17,489,056 | 11,106,032 | 9,536,064 | 12,092,956 | 17,452,055 | 17,014,272 | 13,468,027 | 13,563,034 | 13,938,045 | 12,490,389 | 10,918,300 | 11,570,806 | 19,860,720 | 16,928,159 | 13,862,658 | 14,043,135 | 16,612,630 | 15,340,063 | 13,449,550 | 13,043,898 | 13,575,540 | 12,312,422 | 11,222,646 | 11,353,637 | 13,602,905 | 14,093,176 | 10,209,850 | 10,571,667 | 9,759,264 | 10,659,677 | 9,302,292 | 8,771,326 | 8,874,324 | |||||||||||||||||||||||||||||||||||||||||||||
> Long-term Liabilities |
| 52,221,775 | 51,604,551 | 24,469,060 | 43,658,882 | 41,923,351 | 89,474,742 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Long term Debt Total |
| 0 | 0 | 0 | 24,551,587 | 24,499,521 | 72,504,864 | 72,224,053 | 51,827,652 | 49,529,792 | 29,247,874 | 28,891,769 | 48,566,266 | 23,222,792 | 24,148,837 | 12,215,555 | 9,921,061 | 9,514,446 | 9,573,265 | 7,682,416 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Capital Lease Obligations Min Short Term Debt |
| 0 | 5,398,943 | 5,642,022 | -16,972,566 | -16,959,811 | 3,256,616 | -2,928,845 | -3,051,205 | -1,980,246 | -1,579,730 | -2,273,210 | -1,989,944 | -1,820,327 | -2,011,004 | -12,622,162 | -2,818,187 | -2,591,934 | -2,439,279 | -2,877,077 | 0 | -10,867,279 | 0 | -3,000,000 | -3,000,000 | -5,244,812 | -5,336,425 | -7,365,073 | -8,195,635 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Long-term Liabilities Other |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Deferred Long Term Liability |
| 0 | 0 | 0 | 0 | 0 | 0 | 44,906,937 | 38,563,402 | 33,013,698 | 27,461,117 | 17,391,046 | 14,987,727 | 14,154,780 | 13,606,502 | 13,023,792 | 12,420,985 | 11,759,556 | 10,999,837 | 10,277,461 | 9,618,613 | 8,772,575 | 8,121,744 | 7,315,598 | 14,097,813 | 13,764,994 | 13,360,035 | 11,163,356 | 9,467,149 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
> Total Stockholder Equity |
| 221,805,311 | 220,498,640 | 210,585,565 | 194,171,194 | 189,672,590 | 173,740,959 | 179,594,832 | 176,561,536 | 175,873,584 | 174,094,704 | 177,595,080 | 181,501,887 | 182,352,140 | 186,625,792 | 181,344,824 | 159,922,141 | 157,480,789 | 157,872,156 | 160,092,593 | 152,811,175 | 150,458,940 | 148,518,372 | 150,657,700 | 152,588,433 | 148,094,050 | 146,339,390 | 135,652,480 | 131,095,597 | 127,707,814 | 125,166,062 | 123,713,906 | 121,274,723 | 116,264,988 | 114,316,524 | 111,138,023 | 107,720,156 | 106,330,774 | 105,440,495 | 104,037,232 | 101,274,263 | 95,348,035 | 93,122,654 | 85,187,985 | 81,762,086 | 80,858,029 | |||||||||||||||||||||||||||||||||||||||||||||
Common Stock |
| 0 | 0 | 0 | 11,533,397 | 11,533,397 | 11,384,021 | 11,384,021 | 11,384,021 | 11,384,021 | 11,384,021 | 11,384,021 | 11,384,021 | 11,384,021 | 11,384,021 | 11,384,021 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,052,907 | 11,000,262 | 10,671,228 | 10,671,228 | 10,618,583 | 10,618,583 | 10,618,583 | 10,526,454 | 10,526,454 | 10,526,454 | 10,526,454 | 10,526,454 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
Retained Earnings |
| 0 | 106,015,414 | 101,209,072 | 113,009,663 | 112,404,168 | 112,078,576 | 117,682,425 | 115,022,540 | 114,292,042 | 112,514,106 | 117,321,760 | 121,405,030 | 122,740,162 | 126,987,000 | 121,824,692 | 130,864,826 | 128,392,119 | 128,792,637 | 131,490,191 | 124,181,190 | 121,889,387 | 120,001,443 | 121,965,781 | 123,991,206 | 119,458,353 | 111,080,921 | 107,365,635 | 102,773,008 | 0 | 0 | 0 | 0 | 0 | 0 | 77,494,569 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 63,668,032 | 60,382,948 | 57,932,837 | |||||||||||||||||||||||||||||||||||||||||||||
Capital Surplus |
| 0 | 0 | 0 | 66,648,927 | 62,502,818 | 47,282,563 | 47,194,174 | 46,997,034 | 46,997,034 | 46,911,312 | 46,911,312 | 46,911,312 | 46,911,312 | 46,911,312 | 46,911,312 | 16,525,339 | 16,609,132 | 16,595,514 | 16,595,514 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | 0 | 0 | 0 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | -1,988,327 | ||||||||||||||||||||||||||||||||||||||||||||||
Other Stockholders Equity |
| 0 | 0 | 0 | 3,693,067 | 3,681,935 | 3,605,892 | 2,109,414 | 1,933,143 | 1,975,688 | 2,060,466 | 753,188 | 576,725 | 91,847 | 118,661 | 3,194,725 | 254,271 | 201,832 | 206,300 | 3,213,125 | -243,234 | -303,666 | -356,290 | -181,300 | -275,992 | -237,522 | 6,385,250 | -170,925 | -135,181 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
6.3. Balance Sheets
Currency in KRW. All numbers in thousands.
6.4. Cash Flows
Currency in KRW. All numbers in thousands.
6.5. Income Statements
Currency in KRW. All numbers in thousands.